New Life Medicals is a pharmaceutical sourcing company based in the USA and India, established in 2014. The company's focus lies in global sourcing activities for pharmaceutical goods, including APIs, bulk drugs, reference listed drugs (RLDs), and comparator drugs for clinical trial studies across various therapeutic segments. With a strong network of suppliers from US, EU, Canada, Australia, Japan, China, and Asia, New Life Medicals has gained the trust of clients through ethical business practices.
The company has diversified its presence with entities in the United States, India, and Ireland, allowing access to biosimilars, orphan drugs, REMS, and complex products from global markets to supply the clinical trials and name patient drugs. Additionally, New Life Medicals possesses manufacturing capabilities for finished formulations and serves as a full-time wholesaler and exporter with its own generic and white-labeled products, offering strategic partnerships with various stakeholders.
Despite not having publicly disclosed the latest investment details and investors, New Life Medicals has created a strong foothold in the pharmaceutical sourcing industry and positioned itself as a reliable partner for clinical trials and pharmaceutical supply chain requirements with a global reach.